Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Environ Res. 2021 Jan 15;194:110712. doi: 10.1016/j.envres.2021.110712

Table 4.

Association of urinary phthalate metabolites and maternal glycemic outcomes

Maternal Glycemic Outcome GDMa IGTb GCT Glucose Level (continuous) Excessive GWGc

AORd (95% CI) N =405 AORd (95% CI) N = 316 ABetad (95% CI) N=316 AORd (95% CI) N = 396
Phthalate Metabolitee
MEP 1.1 (0.9, 1.4) 1.0 (0.8, 1.2) − 1.0 (−2.8, 0.9) 1.1 (1.0, 1.3)*
MBP 1.0 (0.8, 1.5) 0.9 (0.7, 1.2) − 0.9 (−3.3, 1.5) 1.1 (0.9, 1.3)
MIBP 1.1 (0.8, 1.4) 1.0 (0.8, 1.3) − 0.3 (−2.5, 1.9) 1.0 (0.9, 1.2)
MBZP 1.1 (0.8, 1.5) 0.9 (0.7, 1.2) − 1.0 (−3.4, 1.3) 1.1 (0.9, 1.2)
ΣDEHP 1.2 (0.8, 1.7) 0.9 (0.7, 1.3) − 0.4 (−3.2, 2.4) 1.1 (0.9, 1.3)
MCPP 1.0 (0.7, 1.4) 1.0 (0.7, 1.3) − 0.9 (−3.4, 1.6) 0.9 (0.8, 1.1)
MCOP 1.1 (0.7, 1.6) 1.0 (0.7, 1.4) − 1.0 (−4.2, 2.3) 1.0 (0.8, 1.2)
MCNP 0.8 (0.6, 1.2) 1.0 ( 0.7, 1.3) − 0.5 (−3.6, 2.6) 0.9 (0.8, 1.1)

Abbreviations: GDM = Gestational Diabetes Mellitus; IGT = Impaired Glucose Tolerance; GCT = Glucose Challenge Test; AOR = Adjusted Odds Ratio; CI = Confidence Interval; ABeta = Adjusted Beta

a

GDM determined by medical record review

b

IGT determined on GCT with glucose threshold value ≥140 mg/dl

c

Excessive GWG determined by Institute of Medicine guidelines

d

AOR were adjusted for maternal age, income, maternal education, marital status, sugar beverage consumption, country of birth, maternal pre-pregnancy BMI

e

Phthalate variable were average of two urinary samples. Variables were logged for normality and adjusted for specific gravity

*

<0.05

**

≤0.01